Here are preliminary results of the bibliometric mapping of the 2022 Luxembourg research evaluation. Its purpose is:
The method for the research-field-mapping can be reviewed here:
Note: The analysis in this document depicts the larger research field around the department, thereby all analysis results are based on the publications of the department plus related
Note: The seed articles deemed representative for
the active areas of research in the institution, and include authors
affiliated with the institution. The departments research field is
identified by selecting the 2000 most similar publications to the
selected seed articles. See Technical descriptionfor
additional explanations.
| AU | PY | TI | JI |
|---|---|---|---|
| SZPAKOWSKA M;DECKER AM;MEYR… | 2021 | THE NATURAL ANALGESIC CONOLIDINE TARGETS THE NEWLY IDENTIFIED OPIOID SCAVENGER ACKR3/CXCR7 | SIGNAL TRANSDUCT. TARGET. T… |
| GOLEBSKI K;LAYHADI JA;SAHIN… | 2021 | INDUCTION OF IL-10-PRODUCING TYPE 2 INNATE LYMPHOID CELLS BY ALLERGEN IMMUNOTHERAPY IS ASSOCIATED… | IMMUNITY |
| MEYRATH M;SZPAKOWSKA M;ZEIN… | 2020 | THE ATYPICAL CHEMOKINE RECEPTOR ACKR3/CXCR7 IS A BROAD-SPECTRUM SCAVENGER FOR OPIOID PEPTIDES | NAT. COMMUN. |
| KURNIAWAN H;FRANCHINA DG;GU… | 2020 | GLUTATHIONE RESTRICTS SERINE METABOLISM TO PRESERVE REGULATORY T CELL FUNCTION | CELL METAB. |
| MARTENS EC;NEUMANN M;DESAI MS | 2018 | INTERACTIONS OF COMMENSAL AND PATHOGENIC MICROORGANISMS WITH THE INTESTINAL MUCOSAL BARRIER | NAT. REV. MICROBIOL. |
Note: This section provides basic descriptives of th
identified research fielld, including number of articles over time,
countries, institutions, and authors. See
Technical descriptionfor additional explanations.
Note: Here, we report the results of a LDA
topic-modelling (basically, clustering on words) on all title+abstract
texts. Identified topics can be interpreted as broad themes in the
research field. See Technical descriptionfor additional
explanations.
Note: While this static vies is helpful, I recommend using the interactive LDAVis version to be found under https://daniel-hain.github.io/biblio_lux_2022/output/topic_modelling/LDAviz_lih_dii.rds/index.html#topic=1&lambda=0.60&term=. For functionality and usage, see ´Technical ´.
Note: This analysis refers the co-citation analysis,
where the cited references and not the original publications are the
unit of analysis. Identified knowledge bases can be interpreted as the
knowledge foundation the field draws from. See
Technical descriptionfor additional explanations.
| name | dgr_int | dgr |
|---|---|---|
| Knowledge Base 1: KB 1: gut microbiota and inflammation (n = 2515, density =2.12) | ||
| MARTENS E.C. CHIANG H.C. GORDON J.I. MUCOSAL GLYCAN FORAGING ENHANCES FITNESS AND TRANSMISSION OF A SACCHAROLYTIC HUMAN GUT BACTERIAL SYMBIONT (2008) | 2362 | 2561 |
| KOROPATKIN N.M. CAMERON E.A. MARTENS E.C. HOW GLYCAN METABOLISM SHAPES THE HUMAN GUT MICROBIOTA (2012) | 2306 | 2537 |
| EL KAOUTARI A. ARMOUGOM F. GORDON J.I. RAOULT D. HENRISSAT B. THE ABUNDANCE AND VARIETY OF CARBOHYDRATE-ACTIVE ENZYMES IN THE HUMAN GUT MICROBIOTA … | 1816 | 1916 |
| JOHANSSON M.E. PHILLIPSON M. PETERSSON J. VELCICH A. HOLM L. HANSSON G.C. THE INNER OF THE TWO MUC2 MUCIN-DEPENDENT MUCUS LAYERS IN COLON IS DEVOID… | 1351 | 1423 |
| SONNENBURG E.D. SMITS S.A. TIKHONOV M. HIGGINBOTTOM S.K. WINGREEN N.S. SONNENBURG J.L. DIET-INDUCED EXTINCTIONS IN THE GUT MICROBIOTA COMPOUND OVER… | 1254 | 1310 |
| TAILFORD L.E. CROST E.H. KAVANAUGH D. JUGE N. MUCIN GLYCAN FORAGING IN THE HUMAN GUT MICROBIOME (2015) | 1201 | 1273 |
| FURUSAWA Y. OBATA Y. FUKUDA S. ENDO T.A. NAKATO G. TAKAHASHI D. COMMENSAL MICROBE-DERIVED BUTYRATE INDUCES THE DIFFERENTIATION OF COLONIC REGULATOR… | 1053 | 1692 |
| ROUND J.L. MAZMANIAN S.K. INDUCIBLE FOXP3+ REGULATORY T-CELL DEVELOPMENT BY A COMMENSAL BACTERIUM OF THE INTESTINAL MICROBIOTA (2010) | 1046 | 1368 |
| KOROPATKIN N.M. MARTENS E.C. GORDON J.I. SMITH T.J. STARCH CATABOLISM BY A PROMINENT HUMAN GUT SYMBIONT IS DIRECTED BY THE RECOGNITION OF AMYLOSE H… | 1020 | 1044 |
| FURUSAWA Y. OBATA Y. FUKUDA S. ENDO T.A. NAKATO G. TAKAHASHI D. NAKANISHI Y. KATO T. COMMENSAL MICROBE-DERIVED BUTYRATE INDUCES THE DIFFERENTIATION… | 1006 | 1093 |
| Knowledge Base 2: KB 2: regulation of lymphocyte metabolism (n = 1515, density =5.23) | ||
| MACIVER N.J. MICHALEK R.D. RATHMELL J.C. METABOLIC REGULATION OF T LYMPHOCYTES (2013) | 2627 | 2844 |
| MICHALEK R.D. GERRIETS V.A. JACOBS S.R. MACINTYRE A.N. MACIVER N.J. MASON E.F. SULLIVAN S.A. RATHMELL J.C. CUTTING EDGE: DISTINCT GLYCOLYTIC AND LI… | 2223 | 2499 |
| ZENG H. YANG K. CLOER C. NEALE G. VOGEL P. CHI H. MTORC1 COUPLES IMMUNE SIGNALS AND METABOLIC PROGRAMMING TO ESTABLISH T(REG) | 2144 | 3046 |
| PEARCE E.L. POFFENBERGER M.C. CHANG C.H. JONES R.G. FUELING IMMUNITY: INSIGHTS INTO METABOLISM AND LYMPHOCYTE FUNCTION (2013) | 1651 | 1904 |
| SHI L.Z. WANG R. HUANG G. VOGEL P. NEALE G. GREEN D.R. CHI H. HIF1ALPHA-DEPENDENT GLYCOLYTIC PATHWAY ORCHESTRATES A METABOLIC CHECKPOINT FOR THE DI… | 1605 | 1774 |
| SINCLAIR L.V. ROLF J. EMSLIE E. SHI Y.B. TAYLOR P.M. CANTRELL D.A. CONTROL OF AMINO-ACID TRANSPORT BY ANTIGEN RECEPTORS COORDINATES THE METABOLIC R… | 1556 | 1754 |
| SHI L.Z. WANG R. HUANG G. VOGEL P. NEALE G. GREEN D.R. HIF1ALPHA-DEPENDENT GLYCOLYTIC PATHWAY ORCHESTRATES A METABOLIC CHECKPOINT FOR THE DIFFERENT… | 1547 | 2001 |
| PENG M. YIN N. CHHANGAWALA S. XU K. LESLIE C.S. LI M.O. AEROBIC GLYCOLYSIS PROMOTES T HELPER 1 CELL DIFFERENTIATION THROUGH AN EPIGENETIC MECHANISM… | 1501 | 1650 |
| MICHALEK R.D. GERRIETS V.A. JACOBS S.R. MACINTYRE A.N. MACIVER N.J. MASON E.F. CUTTING EDGE: DISTINCT GLYCOLYTIC AND LIPID OXIDATIVE METABOLIC PROG… | 1441 | 1753 |
| BUCK M.D. O’SULLIVAN D. PEARCE E.L. T CELL METABOLISM DRIVES IMMUNITY (2015) | 1397 | 1538 |
| Knowledge Base 3: KB 3: Regulatory T cell function (n = 1400, density =4.88) | ||
| HORI S. NOMURA T. SAKAGUCHI S. CONTROL OF REGULATORY T CELL DEVELOPMENT BY THE TRANSCRIPTION FACTOR FOXP3 (2003) | 6308 | 7084 |
| FONTENOT J.D. GAVIN M.A. RUDENSKY A.Y. FOXP3 PROGRAMS THE DEVELOPMENT AND FUNCTION OF CD4+CD25+ REGULATORY T CELLS (2003) | 5095 | 5664 |
| ZHENG Y. JOSEFOWICZ S. CHAUDHRY A. PENG X.P. FORBUSH K. RUDENSKY A.Y. ROLE OF CONSERVED NON-CODING DNA ELEMENTS IN THE FOXP3 GENE IN REGULATORY T-C… | 1994 | 2336 |
| SAKAGUCHI S. SAKAGUCHI N. ASANO M. ITOH M. TODA M. IMMUNOLOGIC SELF-TOLERANCE MAINTAINED BY ACTIVATED T CELLS EXPRESSING IL-2 RECEPTOR ALPHA-CHAINS… | 1742 | 2055 |
| JOSEFOWICZ S.Z. LU L.F. RUDENSKY A.Y. REGULATORY T CELLS: MECHANISMS OF DIFFERENTIATION AND FUNCTION (2012) | 1694 | 2050 |
| KHATTRI R. COX T. YASAYKO S.A. RAMSDELL F. AN ESSENTIAL ROLE FOR SCURFIN IN CD4+CD25+ T REGULATORY CELLS (2003) | 1576 | 1655 |
| SAKAGUCHI S. YAMAGUCHI T. NOMURA T. ONO M. REGULATORY T CELLS AND IMMUNE TOLERANCE (2008) | 1407 | 1575 |
| LI X. LIANG Y. LEBLANC M. BENNER C. ZHENG Y. FUNCTION OF A FOXP3 CIS-ELEMENT IN PROTECTING REGULATORY T CELL IDENTITY (2014) | 1192 | 1329 |
| LEVINE A.G. ARVEY A. JIN W. RUDENSKY A.Y. CONTINUOUS REQUIREMENT FOR THE TCR IN REGULATORY T CELL FUNCTION (2014) | 957 | 1059 |
| FENG Y. ARVEY A. CHINEN T. VAN DER VEEKEN J. GASTEIGER G. RUDENSKY A.Y. CONTROL OF THE INHERITANCE OF REGULATORY T CELL IDENTITY BY A CIS ELEMENT I… | 949 | 1088 |
| Knowledge Base 4: KB 4: serine and one-carbon metabolism in cancer (n = 1279, density =5.5) | ||
| LOCASALE J.W. SERINE GLYCINE AND ONE-CARBON UNITS: CANCER METABOLISM IN FULL CIRCLE (2013) | 2513 | 2619 |
| DUCKER G.S. RABINOWITZ J.D. ONE-CARBON METABOLISM IN HEALTH AND DISEASE (2017) | 1728 | 1793 |
| POSSEMATO R. MARKS K.M. SHAUL Y.D. PACOLD M.E. KIM D. BIRSOY K. SETHUMADHAVAN S. JHA A.K. FUNCTIONAL GENOMICS REVEAL THAT THE SERINE SYNTHESIS PATH… | 1661 | 1718 |
| LOCASALE J.W. GRASSIAN A.R. MELMAN T. LYSSIOTIS C.A. MATTAINI K.R. BASS A.J. HEFFRON G. SHARFI H. PHOSPHOGLYCERATE DEHYDROGENASE DIVERTS GLYCOLYTIC… | 1653 | 1721 |
| FAN J. YE J. KAMPHORST J.J. SHLOMI T. THOMPSON C.B. RABINOWITZ J.D. QUANTITATIVE FLUX ANALYSIS REVEALS FOLATE-DEPENDENT NADPH PRODUCTION (2014) | 1503 | 1568 |
| TIBBETTS A.S. APPLING D.R. COMPARTMENTALIZATION OF MAMMALIAN FOLATE-MEDIATED ONE-CARBON METABOLISM (2010) | 1502 | 1525 |
| MADDOCKS O.D. BERKERS C.R. MASON S.M. ZHENG L. BLYTH K. GOTTLIEB E. VOUSDEN K.H. SERINE STARVATION INDUCES STRESS AND P53-DEPENDENT METABOLIC REMOD… | 1336 | 1370 |
| LABUSCHAGNE C.F. VAN DEN BROEK N.J. MACKAY G.M. VOUSDEN K.H. MADDOCKS O.D. SERINE BUT NOT GLYCINE SUPPORTS ONE-CARBON METABOLISM AND PROLIFERATION … | 1257 | 1278 |
| VANDER HEIDEN M.G. CANTLEY L.C. THOMPSON C.B. UNDERSTANDING THE WARBURG EFFECT: THE METABOLIC REQUIREMENTS OF CELL PROLIFERATION (2009) | 1235 | 2524 |
| YANG M. VOUSDEN K.H. SERINE AND ONE-CARBON METABOLISM IN CANCER (2016) | 1233 | 1298 |
| Knowledge Base 5: KB 5: allergen immunotherapy (n = 1238, density =5.87) | ||
| COX L. NELSON H. LOCKEY R. CALABRIA C. CHACKO T. FINEGOLD I. ALLERGEN IMMUNOTHERAPY: A PRACTICE PARAMETER THIRD UPDATE (2011) | 1118 | 1124 |
| CANONICA G.W. COX L. PAWANKAR R. SUBLINGUAL IMMUNOTHERAPY: WORLD ALLERGY ORGANIZATION POSITION PAPER 2013 UPDATE (2014) | 999 | 999 |
| AKDIS M. AKDIS C.A. MECHANISMS OF ALLERGEN-SPECIFIC IMMUNOTHERAPY: MULTIPLE SUPPRESSOR FACTORS AT WORK IN IMMUNE TOLERANCE TO ALLERGENS (2014) | 945 | 986 |
| JUTEL M. JAEGER L. SUCK R. MEYER H. FIEBIG H. CROMWELL O. ALLERGEN-SPECIFIC IMMUNOTHERAPY WITH RECOMBINANT GRASS POLLEN ALLERGENS (2005) | 916 | 937 |
| DURHAM S.R. EMMINGER W. KAPP A. SQ-STANDARDIZED SUBLINGUAL GRASS IMMUNOTHERAPY: CONFIRMATION OF DISEASE MODIFICATION 2 YEARS AFTER 3 YEARS OF TREAT… | 913 | 913 |
| CANONICA G.W. COX L. PAWANKAR R. BAENA-CAGNANI C.E. BLAISS M. BONINI S. SUBLINGUAL IMMUNOTHERAPY: WORLD ALLERGY ORGANIZATION POSITION PAPER 2013 UP… | 906 | 906 |
| SHAMJI M.H. DURHAM S.R. MECHANISMS OF ALLERGEN IMMUNOTHERAPY FOR INHALED ALLERGENS AND PREDICTIVE BIOMARKERS (2017) | 853 | 880 |
| DURHAM S.R. EMMINGER W. KAPP A. DE MONCHY J.G. RAK S. SCADDING G.K. SQ-STANDARDIZED SUBLINGUAL GRASS IMMUNOTHERAPY: CONFIRMATION OF DISEASE MODIFIC… | 844 | 847 |
| DURHAM S.R. WALKER S.M. VARGA E.M. LONG-TERM CLINICAL EFFICACY OF GRASS-POLLEN IMMUNOTHERAPY (1999) | 840 | 843 |
| BLAISS M. MALONEY J. NOLTE H. GAWCHIK S. YAO R. SKONER D.P. EFFICACY AND SAFETY OF TIMOTHY GRASS ALLERGY IMMUNOTHERAPY TABLETS IN NORTH AMERICAN CH… | 830 | 830 |
| Knowledge Base 6: KB 6: innate lymphoid cell biology (n = 1137, density =7.84) | ||
| GASTEIGER G. FAN X. DIKIY S. LEE S.Y. RUDENSKY A.Y. TISSUE RESIDENCY OF INNATE LYMPHOID CELLS IN LYMPHOID AND NONLYMPHOID ORGANS (2015) | 2297 | 2310 |
| BARTEMES K.R. KEPHART G.M. FOX S.J. KITA H. ENHANCED INNATE TYPE 2 IMMUNE RESPONSE IN PERIPHERAL BLOOD FROM PATIENTS WITH ASTHMA (2014) | 1535 | 1535 |
| SILVER J.S. KEARLEY J. COPENHAVER A.M. SANDEN C. MORI M. YU L. INFLAMMATORY TRIGGERS ASSOCIATED WITH EXACERBATIONS OF COPD ORCHESTRATE PLASTICITY O… | 1452 | 1461 |
| DOHERTY T.A. KHORRAM N. LUND S. MEHTA A.K. CROFT M. BROIDE D.H. LUNG TYPE 2 INNATE LYMPHOID CELLS EXPRESS CYSTEINYL LEUKOTRIENE RECEPTOR 1 WHICH RE… | 1210 | 1210 |
| CONSTANTINIDES M.G. MCDONALD B.D. VERHOEF P.A. BENDELAC A. A COMMITTED PRECURSOR TO INNATE LYMPHOID CELLS (2014) | 1206 | 1210 |
| ARTIS D. SPITS H. THE BIOLOGY OF INNATE LYMPHOID CELLS (2015) | 1189 | 1265 |
| LAO-ARAYA M. STEVELING E. SCADDING G.W. DURHAM S.R. SHAMJI M.H. SEASONAL INCREASES IN PERIPHERAL INNATE LYMPHOID TYPE 2 CELLS ARE INHIBITED BY SUBC… | 1118 | 1606 |
| VIVIER E. ARTIS D. COLONNA M. DIEFENBACH A. DI SANTO J.P. EBERL G. INNATE LYMPHOID CELLS: 10 YEARS ON (2018) | 1079 | 1079 |
| OHNE Y. SILVER J.S. THOMPSON-SNIPES L. COLLET M.A. BLANCK J.P. CANTAREL B.L. IL-1 IS A CRITICAL REGULATOR OF GROUP 2 INNATE LYMPHOID CELL FUNCTION … | 918 | 918 |
| VON MOLTKE J. JI M. LIANG H.E. LOCKSLEY R.M. TUFT-CELL-DERIVED IL-25 REGULATES AN INTESTINAL ILC2-EPITHELIAL RESPONSE CIRCUIT (2016) | 911 | 1254 |
| Knowledge Base 7: KB 7: chemokine receptor CXCR (n = 1055, density =4.15) | ||
| LEVOYE A. BALABANIAN K. BALEUX F. BACHELERIE F. LAGANE B. CXCR7 HETERODIMERIZES WITH CXCR4 AND REGULATES CXCL12-MEDIATED G PROTEIN SIGNALING (2009) | 2270 | 2283 |
| LUKER K.E. STEELE J.M. MIHALKO L.A. RAY P. LUKER G.D. CONSTITUTIVE AND CHEMOKINE-DEPENDENT INTERNALIZATION AND RECYCLING OF CXCR7 IN BREAST CANCER … | 900 | 903 |
| ZLOTNIK A. YOSHIE O. THE CHEMOKINE SUPERFAMILY REVISITED (2012) | 815 | 821 |
| BURNS J.M. SUMMERS B.C. WANG Y. MELIKIAN A. BERAHOVICH R. MIAO Z. A NOVEL CHEMOKINE RECEPTOR FOR SDF-1 AND I-TAC INVOLVED IN CELL SURVIVAL CELL ADH… | 799 | 802 |
| DISSOCIATION OF CXCR4 ACTIVATION FROM BINDING AND INHIBITION OF HIV-1 (1997) | 754 | 760 |
| GRIFFITH J.W. SOKOL C.L. LUSTER A.D. CHEMOKINES AND CHEMOKINE RECEPTORS: POSITIONING CELLS FOR HOST DEFENSE AND IMMUNITY (2014) | 644 | 651 |
| KALATSKAYA I. BERCHICHE Y.A. GRAVEL S. LIMBERG B.J. ROSENBAUM J.S. HEVEKER N. AMD3100 IS A CXCR7 LIGAND WITH ALLOSTERIC AGONIST PROPERTIES (2009) | 644 | 644 |
| GRAHAM G.J. LOCATI M. MANTOVANI A. ROT A. THELEN M. THE BIOCHEMISTRY AND BIOLOGY OF THE ATYPICAL CHEMOKINE RECEPTORS (2012) | 519 | 519 |
| ZLOTNIK A. YOSHIE O. CHEMOKINES: A NEW CLASSIFICATION SYSTEM AND THEIR ROLE IN IMMUNITY (2000) | 497 | 497 |
| NAUMANN U. CAMERONI E. PRUENSTER M. MAHABALESHWAR H. RAZ E. ZERWES H.G. ROT A. THELEN M. CXCR7 FUNCTIONS AS A SCAVENGER FOR CXCL12 AND CXCL11 (2010) | 475 | 475 |
| Knowledge Base 8: KB 8: gut microbiota and immunity (n = 713, density =8.23) | ||
| FURUSAWA Y. COMMENSAL MICROBE-DERIVED BUTYRATE INDUCES THE DIFFERENTIATION OF COLONIC REGULATORY T CELLS (2013) | 1485 | 1761 |
| SMITH P.M. THE MICROBIAL METABOLITES SHORT-CHAIN FATTY ACIDS REGULATE COLONIC TREG CELL HOMEOSTASIS (2013) | 1095 | 1276 |
| IVANOV I.I. INDUCTION OF INTESTINAL TH17 CELLS BY SEGMENTED FILAMENTOUS BACTERIA (2009) | 989 | 1111 |
| DAVID L.A. DIET RAPIDLY AND REPRODUCIBLY ALTERS THE HUMAN GUT MICROBIOME (2014) | 813 | 942 |
| ATARASHI K. TREG INDUCTION BY A RATIONALLY SELECTED MIXTURE OF CLOSTRIDIA STRAINS FROM THE HUMAN MICROBIOTA (2013) | 765 | 918 |
| ARPAIA N. METABOLITES PRODUCED BY COMMENSAL BACTERIA PROMOTE PERIPHERAL REGULATORY T-CELL GENERATION (2013) | 703 | 886 |
| ATARASHI K. INDUCTION OF COLONIC REGULATORY T CELLS BY INDIGENOUS CLOSTRIDIUM SPECIES (2011) | 670 | 770 |
| NG K.M. MICROBIOTA-LIBERATED HOST SUGARS FACILITATE POST-ANTIBIOTIC EXPANSION OF ENTERIC PATHOGENS (2013) | 640 | 747 |
| STRUCTURE FUNCTION AND DIVERSITY OF THE HEALTHY HUMAN MICROBIOME (2012) | 631 | 1512 |
| BUFFIE C.G. PRECISION MICROBIOME RECONSTITUTION RESTORES BILE ACID MEDIATED RESISTANCE TO CLOSTRIDIUM DIFFICILE (2015) | 574 | 611 |
| Knowledge Base 9: KB 9: arrestin-mediated signaling pathways (n = 654, density =5.73) | ||
| AL-HASANI R. BRUCHAS M.R. MOLECULAR MECHANISMS OF OPIOID RECEPTOR-DEPENDENT SIGNALING AND BEHAVIOR (2011) | 409 | 409 |
| BOHN L.M. GAINETDINOV R.R. LIN F.T. LEFKOWITZ R.J. CARON M.G. MU-OPIOID RECEPTOR DESENSITIZATION BY BETA-ARRESTIN-2 DETERMINES MORPHINE TOLERANCE B… | 373 | 373 |
| BOHN L.M. LEFKOWITZ R.J. GAINETDINOV R.R. PEPPEL K. CARON M.G. LIN F.T. ENHANCED MORPHINE ANALGESIA IN MICE LACKING BETA-ARRESTIN 2 (1999) | 358 | 358 |
| GUREVICH E.V. GUREVICH V.V. ARRESTINS ARE UBIQUITOUS REGULATORS OF CELLULAR SIGNALING PATHWAYS (2006) | 324 | 324 |
| PETERSON Y.K. LUTTRELL L.M. THE DIVERSE ROLES OF ARRESTIN SCAFFOLDS IN G PROTEIN-COUPLED RECEPTOR SIGNALING (2017) | 310 | 310 |
| CARPENTER B. NEHMÉ R. WARNE T. LESLIE A.G. TATE C.G. STRUCTURE OF THE ADENOSINE A(2A) | 302 | 302 |
| SCHMID C.L. KENNEDY N.M. ROSS N.C. LOVELL K.M. YUE Z. MORGENWECK J. CAMERON M.D. BOHN L.M. BIAS FACTOR AND THERAPEUTIC WINDOW CORRELATE TO PREDICT … | 295 | 295 |
| SONG X. COFFA S. FU H. GUREVICH V.V. HOW DOES ARRESTIN ASSEMBLE MAPKS INTO A SIGNALING COMPLEX? (2009) | 292 | 292 |
| INDRISCHEK H. PROHASKA S.J. GUREVICH V.V. GUREVICH E.V. STADLER P.F. UNCOVERING MISSING PIECES: DUPLICATION AND DELETION HISTORY OF ARRESTINS IN DE… | 285 | 285 |
| GUREVICH V.V. GUREVICH E.V. THE MOLECULAR ACROBATICS OF ARRESTIN ACTIVATION (2004) | 280 | 280 |
Note: This analysis refers the bibliographic
coupling analysis, where original publications are the unit of analysis.
Identified research areas can be interpreted as the field’s current
research frontier. See Technical descriptionfor additional
explanations.
| AU | PY | TI | dgr_int | TC | TC_year |
|---|---|---|---|---|---|
| Research Area 1: RA 1: impact of diet-microbiota interactions on immunity (n = 1077, density =0.15) | |||||
| KOH A;DE VADDER F;KOVA… | 2016 | FROM DIETARY FIBER TO HOST PHYSIOLOGY: SHORT-CHAIN FATTY ACIDS AS KEY BACTERIAL METABOLITES | 3.34 | 2285 | 380.83 |
| THURSBY E;JUGE N | 2017 | INTRODUCTION TO THE HUMAN GUT MICROBIOTA | 5.11 | 995 | 199.00 |
| SONNENBURG JL;BÄCKHED F | 2016 | DIET-MICROBIOTA INTERACTIONS AS MODERATORS OF HUMAN METABOLISM | 4.15 | 1067 | 177.83 |
| DESAI MS;SEEKATZ AM;KO… | 2016 | A DIETARY FIBER-DEPRIVED GUT MICROBIOTA DEGRADES THE COLONIC MUCUS BARRIER AND ENHANCES PATHOGEN SUSCEPTIBILITY | 4.10 | 1077 | 179.50 |
| ROOKS MG;GARRETT WS | 2016 | GUT MICROBIOTA, METABOLITES AND HOST IMMUNITY | 2.85 | 1323 | 220.50 |
| LEVY M;KOLODZIEJCZYK A… | 2017 | DYSBIOSIS AND THE IMMUNE SYSTEM | 4.50 | 622 | 124.40 |
| MAKKI K;DEEHAN EC;WALT… | 2018 | THE IMPACT OF DIETARY FIBER ON GUT MICROBIOTA IN HOST HEALTH AND DISEASE | 3.25 | 804 | 201.00 |
| THAISS CA;ZMORA N;LEVY… | 2016 | THE MICROBIOME AND INNATE IMMUNITY | 2.37 | 927 | 154.50 |
| BELKAID Y;HARRISON OJ | 2017 | HOMEOSTATIC IMMUNITY AND THE MICROBIOTA | 4.36 | 495 | 99.00 |
| BAÜMLER AJ;SPERANDIO V | 2016 | INTERACTIONS BETWEEN THE MICROBIOTA AND PATHOGENIC BACTERIA IN THE GUT | 3.07 | 595 | 99.17 |
| Research Area 2: RA 2: metabolism of regulatory T cells (n = 580, density =0.33) | |||||
| O’NEILL LAJ;KISHTON RJ… | 2016 | A GUIDE TO IMMUNOMETABOLISM FOR IMMUNOLOGISTS | 2.40 | 1262 | 210.33 |
| BUCK MD;SOWELL RT;KAEC… | 2017 | METABOLIC INSTRUCTION OF IMMUNITY | 3.57 | 549 | 109.80 |
| SUKUMAR M;LIU J;MEHTA … | 2016 | MITOCHONDRIAL MEMBRANE POTENTIAL IDENTIFIES CELLS WITH ENHANCED STEMNESS FOR CELLULAR THERAPY | 6.69 | 201 | 33.50 |
| KISHTON RJ;SUKUMAR M;R… | 2017 | METABOLIC REGULATION OF T CELL LONGEVITY AND FUNCTION IN TUMOR IMMUNOTHERAPY | 5.28 | 199 | 39.80 |
| JOHNSON MO;WOLF MM;MAD… | 2018 | DISTINCT REGULATION OF TH17 AND TH1 CELL DIFFERENTIATION BY GLUTAMINASE-DEPENDENT METABOLISM | 3.86 | 243 | 60.75 |
| LOFTUS RM;FINLAY DK | 2016 | IMMUNOMETABOLISM: CELLULAR METABOLISM TURNS IMMUNE REGULATOR | 3.23 | 238 | 39.67 |
| ALMEIDA L;LOCHNER M;BE… | 2016 | METABOLIC PATHWAYS IN T CELL ACTIVATION AND LINEAGE DIFFERENTIATION | 2.98 | 217 | 36.17 |
| NEWTON R;PRIYADHARSHIN… | 2016 | IMMUNOMETABOLISM OF REGULATORY T CELLS | 3.24 | 196 | 32.67 |
| MENK AV;SCHARPING NE;M… | 2018 | EARLY TCR SIGNALING INDUCES RAPID AEROBIC GLYCOLYSIS ENABLING DISTINCT ACUTE T CELL EFFECTOR FUNCTIONS | 3.54 | 178 | 44.50 |
| GERRIETS VA;KISHTON RJ… | 2016 | FOXP3 AND TOLL-LIKE RECEPTOR SIGNALING BALANCE T REG CELL ANABOLIC METABOLISM FOR SUPPRESSION | 2.28 | 276 | 46.00 |
| Research Area 3: RA 3: Regulatory T cells in diseases (n = 462, density =0.81) | |||||
| CHINEN T;KANNAN AK;LEV… | 2016 | AN ESSENTIAL ROLE FOR THE IL-2 RECEPTOR IN T REG CELL FUNCTION | 7.08 | 393 | 65.50 |
| KAMADA T;TOGASHI Y;TAY… | 2019 | PD-1+ REGULATORY T CELLS AMPLIFIED BY PD-1 BLOCKADE PROMOTE HYPERPROGRESSION OF CANCER | 6.44 | 361 | 120.33 |
| TOGASHI Y;SHITARA K;NI… | 2019 | REGULATORY T CELLS IN CANCER IMMUNOSUPPRESSION — IMPLICATIONS FOR ANTICANCER THERAPY | 4.81 | 440 | 146.67 |
| DOMINGUEZ-VILLAR M;HAF… | 2018 | REGULATORY T CELLS IN AUTOIMMUNE DISEASE | 7.24 | 282 | 70.50 |
| MAJ T;WANG W;CRESPO J;… | 2017 | OXIDATIVE STRESS CONTROLS REGULATORY T CELL APOPTOSIS AND SUPPRESSOR ACTIVITY AND PD-L1-BLOCKADE RESISTANCE IN TUMOR | 5.27 | 341 | 68.20 |
| LI MO;RUDENSKY AY | 2016 | T CELL RECEPTOR SIGNALLING IN THE CONTROL OF REGULATORY T CELL DIFFERENTIATION AND FUNCTION | 6.37 | 269 | 44.83 |
| WING JB;TANAKA A;SAKAG… | 2019 | HUMAN FOXP3 + REGULATORY T CELL HETEROGENEITY AND FUNCTION IN AUTOIMMUNITY AND CANCER | 6.51 | 250 | 83.33 |
| PLITAS G;RUDENSKY AY | 2016 | REGULATORY T CELLS: DIFFERENTIATION AND FUNCTION | 10.96 | 142 | 23.67 |
| TAKEUCHI Y;NISHIKAWA H | 2016 | ROLES OF REGULATORY T CELLS IN CANCER IMMUNITY | 5.18 | 284 | 47.33 |
| KITAGAWA Y;OHKURA N;KI… | 2017 | GUIDANCE OF REGULATORY T CELL DEVELOPMENT BY SATB1-DEPENDENT SUPER-ENHANCER ESTABLISHMENT | 7.20 | 184 | 36.80 |
| Research Area 4: RA 4: serine and one-carbon metabolism in cancer (n = 462, density =0.45) | |||||
| PAVLOVA NN;THOMPSON CB | 2016 | THE EMERGING HALLMARKS OF CANCER METABOLISM | 3.16 | 2546 | 424.33 |
| DUCKER GS;RABINOWITZ JD | 2017 | ONE-CARBON METABOLISM IN HEALTH AND DISEASE | 5.55 | 738 | 147.60 |
| DE BERARDINIS RJ;CHAND… | 2016 | FUNDAMENTALS OF CANCER METABOLISM | 3.19 | 1281 | 213.50 |
| VANDER HEIDEN MG;DEBER… | 2017 | UNDERSTANDING THE INTERSECTIONS BETWEEN METABOLISM AND CANCER BIOLOGY | 3.80 | 981 | 196.20 |
| YANG M;VOUSDEN KH | 2016 | SERINE AND ONE-CARBON METABOLISM IN CANCER | 4.57 | 433 | 72.17 |
| NEWMAN AC;MADDOCKS ODK | 2017 | ONE-CARBON METABOLISM IN CANCER | 9.27 | 189 | 37.80 |
| LUENGO A;GUI DY;VANDER… | 2017 | TARGETING METABOLISM FOR CANCER THERAPY | 3.97 | 403 | 80.60 |
| MATTAINI KR;SULLIVAN M… | 2016 | THE IMPORTANCE OF SERINE METABOLISM IN CANCER | 7.48 | 186 | 31.00 |
| MA EH;BANTUG G;GRISS T… | 2017 | SERINE IS AN ESSENTIAL METABOLITE FOR EFFECTOR T CELL EXPANSION | 4.44 | 263 | 52.60 |
| PACOLD ME;BRIMACOMBE K… | 2016 | A PHGDH INHIBITOR REVEALS COORDINATION OF SERINE SYNTHESIS AND ONE-CARBON UNIT FATE | 4.06 | 250 | 41.67 |
| Research Area 5: RA 5: allergen immunotherapy (n = 429, density =0.35) | |||||
| SHAMJI MH;DURHAM SR | 2017 | MECHANISMS OF ALLERGEN IMMUNOTHERAPY FOR INHALED ALLERGENS AND PREDICTIVE BIOMARKERS | 5.37 | 226 | 45.20 |
| ROBERTS G;PFAAR O;AKDI… | 2018 | EAACI GUIDELINES ON ALLERGEN IMMUNOTHERAPY: ALLERGIC RHINOCONJUNCTIVITIS | 3.95 | 297 | 74.25 |
| SHAMJI MH;KAPPEN JH;AK… | 2017 | BIOMARKERS FOR MONITORING CLINICAL EFFICACY OF ALLERGEN IMMUNOTHERAPY FOR ALLERGIC RHINOCONJUNCTIVITIS AND ALLERGIC ASTHMA… | 5.08 | 198 | 39.60 |
| DEMOLY P;EMMINGER W;RE… | 2016 | EFFECTIVE TREATMENT OF HOUSE DUST MITE-INDUCED ALLERGIC RHINITIS WITH 2 DOSES OF THE SQ HDM SLIT-TABLET: RESULTS FROM A RA… | 3.82 | 146 | 24.33 |
| DURHAM SR;PENAGOS M | 2016 | SUBLINGUAL OR SUBCUTANEOUS IMMUNOTHERAPY FOR ALLERGIC RHINITIS? | 5.32 | 100 | 16.67 |
| VIRCHOW JC;BACKER V;KU… | 2016 | EFFICACY OF A HOUSE DUST MITE SUBLINGUAL ALLERGEN IMMUNOTHERAPY TABLET IN ADULTS WITH ALLERGIC ASTHMA: A RANDOMIZED CLINIC… | 1.46 | 257 | 42.83 |
| SCADDING GW;CALDERON M… | 2017 | EFFECT OF 2 YEARS OF TREATMENT WITH SUBLINGUAL GRASS POLLEN IMMUNOTHERAPY ON NASAL RESPONSE TO ALLERGEN CHALLENGE AT 3 YEA… | 2.99 | 124 | 24.80 |
| JUTEL M;AGACHE I;BONIN… | 2016 | INTERNATIONAL CONSENSUS ON ALLERGEN IMMUNOTHERAPY II: MECHANISMS, STANDARDIZATION, AND PHARMACOECONOMICS | 2.26 | 155 | 25.83 |
| DHAMI S;NURMATOV U;ARA… | 2017 | ALLERGEN IMMUNOTHERAPY FOR ALLERGIC RHINOCONJUNCTIVITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS | 1.89 | 167 | 33.40 |
| NOLTE H;BERNSTEIN DI;N… | 2016 | EFFICACY OF HOUSE DUST MITE SUBLINGUAL IMMUNOTHERAPY TABLET IN NORTH AMERICAN ADOLESCENTS AND ADULTS IN A RANDOMIZED, PLAC… | 3.13 | 94 | 15.67 |
| Research Area 6: RA 6: CXCR chemokine receptors in diseases (n = 348, density =0.3) | |||||
| HUGHES CE;NIBBS RJB | 2018 | A GUIDE TO CHEMOKINES AND THEIR RECEPTORS | 1.61 | 345 | 86.25 |
| JANSSENS R;STRUYF S;PR… | 2018 | THE UNIQUE STRUCTURAL AND FUNCTIONAL FEATURES OF CXCL12 | 2.98 | 129 | 32.25 |
| POZZOBON T;GOLDONI G;V… | 2016 | CXCR4 SIGNALING IN HEALTH AND DISEASE | 3.04 | 124 | 20.67 |
| BONECCHI R;GRAHAM GJ | 2016 | ATYPICAL CHEMOKINE RECEPTORS AND THEIR ROLES IN THE RESOLUTION OF THE INFLAMMATORY RESPONSE | 2.76 | 89 | 14.83 |
| STONE MJ;HAYWARD JA;HU… | 2017 | MECHANISMS OF REGULATION OF THE CHEMOKINE-RECEPTOR NETWORK | 1.24 | 141 | 28.20 |
| GIRBL T;LENN T;PEREZ L… | 2018 | DISTINCT COMPARTMENTALIZATION OF THE CHEMOKINES CXCL1 AND CXCL2 AND THE ATYPICAL RECEPTOR ACKR1 DETERMINE DISCRETE STAGES … | 1.20 | 127 | 31.75 |
| MASSARA M;BONAVITA O;M… | 2016 | ATYPICAL CHEMOKINE RECEPTORS IN CANCER: FRIENDS OR FOES? | 2.51 | 54 | 9.00 |
| HAO H;HU S;CHEN H;BU D… | 2017 | LOSS OF ENDOTHELIAL CXCR7 IMPAIRS VASCULAR HOMEOSTASIS AND CARDIAC REMODELING AFTER MYOCARDIAL INFARCTION: IMPLICATIONS FO… | 2.32 | 56 | 11.20 |
| SZPAKOWSKA M;NEVINS AM… | 2018 | DIFFERENT CONTRIBUTIONS OF CHEMOKINE N-TERMINAL FEATURES ATTEST TO A DIFFERENT LIGAND BINDING MODE AND A BIAS TOWARDS ACTI… | 3.89 | 33 | 8.25 |
| CHENG X;WANG H;ZHANG X… | 2017 | THE ROLE OF SDF-1/CXCR4/CXCR7 IN NEURONAL REGENERATION AFTER CEREBRAL ISCHEMIA | 2.03 | 62 | 12.40 |
| Research Area 7: RA 7: innate lymphoid cells function (n = 311, density =0.42) | |||||
| VIVIER E;ARTIS D;COLON… | 2018 | INNATE LYMPHOID CELLS: 10 YEARS ON | 3.97 | 854 | 213.50 |
| HABER AL;BITON M;ROGEL… | 2017 | A SINGLE-CELL SURVEY OF THE SMALL INTESTINAL EPITHELIUM | 0.93 | 632 | 126.40 |
| COLONNA M | 2018 | INNATE LYMPHOID CELLS: DIVERSITY, PLASTICITY, AND UNIQUE FUNCTIONS IN IMMUNITY | 2.82 | 176 | 44.00 |
| EBBO M;CRINIER A;VÉLY … | 2017 | INNATE LYMPHOID CELLS: MAJOR PLAYERS IN INFLAMMATORY DISEASES | 1.83 | 194 | 38.80 |
| KABATA H;MORO K;KOYASU S | 2018 | THE GROUP 2 INNATE LYMPHOID CELL (ILC2) REGULATORY NETWORK AND ITS UNDERLYING MECHANISMS | 2.91 | 117 | 29.25 |
| MORITA H;KUBO T;RÜCKER… | 2019 | INDUCTION OF HUMAN REGULATORY INNATE LYMPHOID CELLS FROM GROUP 2 INNATE LYMPHOID CELLS BY RETINOIC ACID | 3.69 | 86 | 28.67 |
| BAL SM;GOLEBSKI K;SPITS H | 2020 | PLASTICITY OF INNATE LYMPHOID CELL SUBSETS | 2.62 | 111 | 55.50 |
| PANDA SK;COLONNA M | 2019 | INNATE LYMPHOID CELLS IN MUCOSAL IMMUNITY | 3.01 | 94 | 31.33 |
| CORTEZ VS;ULLAND TK;CE… | 2017 | SMAD4 IMPEDES THE CONVERSION OF NK CELLS INTO ILC1-LIKE CELLS BY CURTAILING NON-CANONICAL TGF-Β SIGNALING | 1.32 | 182 | 36.40 |
| GURRAM RK;ZHU J | 2019 | ORCHESTRATION BETWEEN ILC2S AND TH2 CELLS IN SHAPING TYPE 2 IMMUNE RESPONSES | 3.53 | 66 | 22.00 |
| Research Area 8: RA 8: opioid receptor biology (n = 236, density =0.27) | |||||
| WACKER D;STEVENS RC;RO… | 2017 | HOW LIGANDS ILLUMINATE GPCR MOLECULAR PHARMACOLOGY | 1.17 | 281 | 56.20 |
| SMITH JS;LEFKOWITZ RJ;… | 2018 | BIASED SIGNALLING: FROM SIMPLE SWITCHES TO ALLOSTERIC MICROPROCESSORS | 0.71 | 327 | 81.75 |
| WACKER D;WANG S;MCCORV… | 2017 | CRYSTAL STRUCTURE OF AN LSD-BOUND HUMAN SEROTONIN RECEPTOR | 1.13 | 202 | 40.40 |
| INOUE A;RAIMONDI F;KAD… | 2019 | ILLUMINATING G-PROTEIN-COUPLING SELECTIVITY OF GPCRS | 1.10 | 171 | 57.00 |
| GUREVICH VV;GUREVICH EV | 2019 | GPCR SIGNALING REGULATION: THE ROLE OF GRKS AND ARRESTINS | 1.02 | 182 | 60.67 |
| KRISHNA KUMAR K;SHALEV… | 2019 | STRUCTURE OF A SIGNALING CANNABINOID RECEPTOR 1-G PROTEIN COMPLEX | 0.91 | 189 | 63.00 |
| VALENTINO RJ;VOLKOW ND | 2018 | UNTANGLING THE COMPLEXITY OF OPIOID RECEPTOR FUNCTION | 1.15 | 115 | 28.75 |
| CONIBEAR AE;KELLY E | 2019 | A BIASED VIEW OF Μ-OPIOID RECEPTORS? | 2.35 | 54 | 18.00 |
| STAUS DP;HU H;ROBERTSO… | 2020 | STRUCTURE OF THE M2 MUSCARINIC RECEPTOR–Β-ARRESTIN COMPLEX IN A LIPID NANODISC | 1.03 | 121 | 60.50 |
| KIM K;CHE T;PANOVA O;D… | 2020 | STRUCTURE OF A HALLUCINOGEN-ACTIVATED GQ-COUPLED 5-HT2A SEROTONIN RECEPTOR | 1.05 | 100 | 50.00 |
All results are preliminary so far…